Search Results Page

Glenmark Pharma at new low

about 7 years ago

At Rs.379.65, the stock price of Glenmark Pharma hit a 7-year low today and the mood on the counter continues to remain somber.

Are funds shifting from Glenmark Pharma to Glenmark Life?

about 5 years ago

There are cues supporting it. HSBC Global Investment Funds, a FPI, holding 1.3% stake in Glenmark Pharma as of 30.6.21, was an anchor investor in Glenmark Life’s IPO for 3.6% stake.

Glenmark Pharma spurts over 3.5%

about 8 years ago

Glenmark Pharma rose over 3.5% today to hit an intra day high at Rs.603.35 and continues to remain firmly in the green.

Glenmark Pharma on a surge

about 7 years ago

Glenmark Pharma had been on a surge on Friday on the back of its Q2 earnings announcement, And today, the buzz on the stock got louder. Volumes were up over 3.5 times.

Glenmark Pharma down 3%

about 9 years ago

Glenmark Pharma today fell 3% to Rs.573.95; though it has recovered a bit, it now remains in the red at Rs.575 levels. Its 52-week low is not too far away at Rs.565.

Glenmark Pharma in good health

about 9 years ago

Glenmark Pharma rose almost 4.5% to Rs.626.65 during intra day and remains in the green. Its 52-week high and low stands at Rs.993 and Rs.567.95 respectively.

Glenmark Pharma

about 9 years ago

Glenmark Pharma is down in the red today morning; going down to Rs.671.20. Its 52-week low is at Rs.6

Glenmark Pharma tastes bitter

about 10 years ago

Glenmark Pharma is the top loser on the BSE right since the morning. The stock opened breaching the lower circuit at Rs.813.95 and after that continued to only slide.

Glenmark Pharma hits life-time high

about 11 years ago

Glenmark Pharma has hit a life time high of Rs.1228.25 and it is currently at Rs.1225 levels. Volumes are up over 1.5 times. The stock is up as the company has been granted final approval by the United States Food & Drug Administration (US FDA) for Drospirenone and Ethinyl Estradiol tabl ...

Glenmark Pharma hits a new high

about 12 years ago

Glenmark Pharma is amongst the top gainers on the BSE currently, up 6% at Rs.894 and it briefly crossed Rs.900, hitting a new 52-week high at Rs.901.20. Many things going for the company. The Cabinet Committee on Economic Affairs (CCEA) allowed the company yesterday to increase the FII limit ...

Glenmark Pharma in good health

about 12 years ago

Glenmark Pharma is up 2.5% at Rs.553 levels, with an intra day high at Rs.557. This pharma stock has been in the green consistently for some time now. Today, the company has announced receiving the final ANDA approval from US FDA for r Fluocinonide Cream USP 0.1%, the generic version of Vanos ...

Glenmark Pharma gives a Russian smile

about 12 years ago

Glenmark Pharma is on a good run today, with the stock opening stronger at Rs.834.75 and going up to an intra day high at Rs.849.10 The stock is in news today on getting approval from the Russian health ministry for its asthma inhaler – Salmecort MDI. This is a milestone for the company ...

Glenmark Pharma in the red

about 11 years ago

Glenmark Pharma is amongst the top five losers on the BSE currently down almost 4.5% at Rs.950 levels with an intra day low of Rs.929.05. Earlier this month, it had hit a new high at Rs.1105. Two things are presently going against the stock price today. Firstly, the downgrade by FII firm Cre ...

Glenmark Pharma at 25% UC

about 6 years ago

The stock, which had closed on Friday at Rs.409.10, opened at Rs.450 and immediately hit the 25% UC of the day at Rs.511.35

Glenmark Pharma in green

about 5 years ago

The stock price, which had closed yesterday at Rs.509.20, opened today at Rs.513.90 and went on to hit an intraday high at Rs.518.15

Glenmark Pharma brings hope

about 7 years ago

The stock which had closed yesterday at Rs.329.70, opened higher today at Rs.356.40 and went on to hit an intraday high at Rs.359.

Glenmark Pharma up 2.5%

about 5 years ago

The stock went up 2.5% to hit an intraday high at Rs.506.75 on the back of a 2-times rise in volumes. Its 52-week high is at Rs.690.60.

Glenmark Pharma up in green

about 4 years ago

The stock price today rose over 3% to hit an intraday high at Rs.417.15 and is currently trading at Rs.413 levels.

Glenmark Pharma does well

about 3 years ago

From its close of Rs.1080.05, the stock opened today at Rs.1092.60, its intraday high and quite close to its 52-week high of Rs.1095.95. Its come off this level and is presently trading at Rs.1082 levels.

Glenmark Pharma spurts 4.5%

about 8 years ago

The stock price has reacted positively to this news, with the price surging 4.5% to Rs.698, which is too not far fetched from its 52-week high of Rs.711.

Glenmark Pharma up over 9%

about 7 years ago

The stock, which had closed at Rs.318.10 yesterday, opened higher today at Rs.322.40 and went on to hit an intraday high at Rs.346.50.

Glenmark Pharma makes news

about 4 years ago

The stock opened with a positive bias, opening higher at Rs.411.45 and going on to an intraday high at Rs.441. Its 10% UC of the day is at Rs.450.10.

Pharma companies in the red

about 14 years ago

Pharma companies are not doing too well today morning with Glenmark, Dr.Reddy, Lupin, Cipla, Ranbaxy, all in the red. Glenmark is amongst the top losers in the sector, down over 2.2% at Rs.564.60. It has hit a new 52-week only yesterday at Rs.580. The pharma stocks have slipped into the red ...

Glenmark gets bitter pill to swallow

about 12 years ago

The taste has turned bitter for Glenmark Pharma today. The stock is down almost 2% at Rs.817 with an intra day low at Rs.797.50. And on Friday, it has hit a new high at Rs.879.05. This turnaround in moods happened on news report that the Delhi High Court has restrained the c ...

Glenmark looks healthy

about 7 years ago

Glenmark Pharma is making some waves today morning. The stock, which has closed yesterday at Rs.282.30, opened higher at Rs.298 and went on to hit an intraday high at Rs.304.25.

WHEN US FDA MEETS INDIAN PHARMA COMPANIES...

about 9 years ago

This is the thought which comes to mind when we read this news today about Biocon also being pulled by the ‘villain’ of Indian pharma companies – the U.S. Food and Drug Administration (U.S. FDA). The stock was down today as its Bengaluru unit has received ten observations on Form 483 by the FDA. This ranges right from nonconformity to procedures and lack of trained and skilled employees

INDIAN PHARMA - GETTING INTO BETTER HEALTH

about 12 years ago

Yesterday, Cadila Healthcare was the top loser of the day on the BSE and the villain, like in all pharma stories was U.S. Food and Drug Administration (FDA). It has expressed concerns through Form 483, over the manufacturing process of at least one product at its Moraiya facility.

Pharma gets "Trumped"

about 1 year ago

The Nifty Pharma Index fell 5-6% making it the worst-performing sector. Big losers included- Sun Pharma, Dr. Reddy’s, Cipla, Lupin fell between 5 to 8%.

Orhid Pharma hits 10% upper circuit

about 13 years ago

Orchid Pharma has hit the 10% upper circuit at Rs.53.60. It has closed on Friday at Rs.48.75,opening higher at Rs.53. The stock is up on the back of news which came in on 14th March, regarding its CDR approval package. The company stated that the CDR Empowered Group approved the debt restruc ...

Natco Pharma looks healthy

about 13 years ago

Natco Pharma is up over 7% at Rs.815.90, with an intra day high at Rs.826, which was also its new 52-week high. Volumes are up almost 4 times. The stock spiked up to a new high after U.S. Supreme Court justice yesterday declined a request from Teva for a stay of an appeals court ruling. This ...

Elder Pharma back on the buzz

about 13 years ago

Elder Pharma is back on the buzz and the same old buzz too – acquisition of domestic business of the company. The stock is up currently over 4% at Rs.310.40, hitting an intra day high at Rs.317. Volumes are also on the rise. The news is that Torrent Pharma is very close to striking a d ...

Bafna Pharma in the limelight

about 13 years ago

Bafna Pharma has been in the limelight over the past two days. Today, the stock opened at an intra day high of Rs.35.95 and it is currently up almost 9% at Rs.33. Volumes are up 7 times. This small cap pharma stock is in the limelight following grapevine that US based Mylan and two mor ...

Elder Pharma gets 'feverish'

about 13 years ago

Elder Pharma has crashed today morning. The stock is down over 7% at Rs.277.25, with an intra day low at Rs.270.25. The stock is in the red as the market is not enthused with its decision to decision to sell the branded formulations division to Torrent Pharma for about Rs.2000 crore. The mar ...

Torrent Pharma looks healthy

about 13 years ago

Torrent Pharma is doing very well today morning, hitting a new 52-week high at Rs.538.40, with an almost 2 times surge in volumes. It has come off the highs but remains almost 9% up at Rs.517 levels. The stock is up after the company yesterday declared its Q3FY14 numbers after market closure ...

Dishman Pharma in the green

about 13 years ago

Dishman Pharma is on a strong rally today. The stock is up over 2% at Rs.97.10, with an intra day high at Rs.97.95, with a 52-week high at Rs.110.40. The stock is in the green post the news that the company is selling its land to Nirma to pare its debt. The company is reportedly selling its ...

Shasun Pharma in the red

about 13 years ago

Shasun Pharma had been hitting new highs over the past couple of days but since yesterday, it has been in the red. Today, the stock is currently down over 2% at Rs.124.85, and this is after hitting an intra day low at Rs.122.45. The stock is down after news came in yesterday that a a fire ha ...

Torrent Pharma looks healthy

about 13 years ago

Torrent Pharma is on a roll today. There has been increased activity on the counter since yesterday, with volumes spiking up 2.5 times and today too, volumes are up around same levels. The stock is currently up over 3.2% at Rs.568, with an intra day high at Rs.573. It went tantalizingly close to ...

Torrent Pharma looks healthy

about 13 years ago

Torrent Pharma has hit a new high today at Rs.607.70, zooming up in the early morning trade by over 9%. It has since then come off the highs and is currently at Rs.575. Volumes are up 4 times. The stock hit a high, celebrating the news that the CCI has approved the company’s proposed R ...

Alembic Pharma hits new high

about 13 years ago

Alembic Pharma has hit a new 52-week high today at Rs.196.50 and it is currently trading around the same levels, with over 2.4 times surge in volumes. The company, led by a smart spike up in its export sales, posted a stellar set of numbers for Q2FY14, with standalone net profit coming at Rs ...

Aurobindo Pharma hits new high

about 13 years ago

Aurobindo Pharma has been consistently hitting new 52-week highs since 13th May. Yesterday, the stock had closed at Rs.615 and today it opened higher at Rs.624.30, going on to hit a new 52-week high at Rs.632.30. The stock has jumped up on the back of MSCI adding the company in their MSCI In ...

Natco Pharma in 'green' of health!

about 12 years ago

Natco Pharma is currently frozen on the 5% upper circuit at Rs.1114.75 the moment it opened for trading today. Yesterday too, it breached the upper circuit at Rs.1071.90. The stock has been hitting the ceiling, reacting to the very good news for the company that it has won another batt ...

Natco Pharma hits another new high

about 12 years ago

Natco Pharma has been hitting new highs since 25th Aug and today too, it hit a new high at Rs.1262.55, which was also its upper circuit. The stock is reacting to the news it announced on Saturday that its US partner, Mylan Inc has filed for an ANDA. This is for Copaxone, which is a three tim ...

Sun Pharma under a shadow

about 12 years ago

Sun Pharma is currently the top loser on the BSE, down 4.2% at Rs.823.40, with an intra day low at Rs.808, with volumes rising over two times. Th stock has slumped into the red today on unconfirmed reports on TV that a surprise check was conducted at the company’s plant by a ...

Aurobindo Pharma in 'green' of health

about 12 years ago

Shares of Aurobindo Pharma are up over 3% by Rs. 32 a share and are currently trading at 1,033 a piece, having receded from the new 52 week high of 1,043 made a while back. The Hyderabad based pharma company has reported strong performance for the second quarter this morning with 82% YoY rise in ...

Aurobindo Pharma hits new high

about 13 years ago

Aurobindo Pharma is currently the top gainer on the BSE, up almost 10% at Rs.261.70 and this is after having hit a new 52-week high at Rs.463.25. Volumes are up almost 11.5 times. The stock is high on the back of better-than-expected numbers for Q2FY14. Its consolidated net profit was up 6% ...

Ajanta Pharma up over 8%

about 13 years ago

Ajanta Pharma is up over 8% at Rs.672.80, with an intra day high at Rs.702. The intar day low stands at Rs.631.80. Volumes are good at 34,000 shares. Market cap stands at Rs.1576 crore. The stock is in the green has fixed September 18, 2013 as the record date for the purpose of issue of bonu ...

Elder Pharma in the red

about 13 years ago

Shares of Elder Pharma are down close to 3% at Rs 310, with BSE volumes touching 64,000 shares against two-week average of 28,000 shares. Broader indices are trading higher by 1% and CNX Pharma index is down 0.6%. Company’s Chairman and Managing Director, Mr. Jagdish Saxena, ...

SMS Pharma up and about

about 14 years ago

SMS Pharma is buzzing today, up currently 2.27% at Rs.225, its intra day high point. Volumes are muted at 255 shares changing hands and market cap stands at Rs.225 crore. The stock is up after the company announced that it will buy back shares from the open market, at a maximum price of Rs.3 ...

Glenmark tumbles on Venezuela concern

about 11 years ago

The Venezuelan politics is threatening to affect the workings of Glenmark and other Indian companies with a presence there. Yesterday, the country’s Opposition went on to win the elections with a ‘super majority’, indicating a change in the power seat. The biggest task is f ...

Sun Pharma back in reckoning

about 8 years ago

Sun Pharma has gone up back into the green today. The stock rose over 5.5% to Rs.421.50 and remains the top gainer on the BSE since morning.

Glenmark in pink of health

about 13 years ago

Glenmark Pharma is doing very well today morning; it has been the top gainer on the BSE since the morning. The stock is up 5.7% at Rs.538 levels, its intra day high. Volumes are up over 2 times. The stock is up on the back of exuberant Q3FY14 numbers. Its consolidated net profit rose 1.55% t ...

Glenmark slumps on net profit slide

about 13 years ago

Glenmark Pharma is amongst the top losers on the BSE today, the stock is currently down 3% at Rs.545.50, with an intra day high at Rs.540.05. Volumes are up almost 2.5 times. The stock is down on the back of weak Q2FY14 numbers. Its consolidated net profit dropped 1.6% (YoY) at Rs.154 crore ...

Bafna Pharma gets 'Crisil'ed

about 12 years ago

Bafna Pharma continues to celebrate the upgrade in its credit rating by Crisil, announced yesterday. The stock which had closed yesterday at Rs.33, opened today at Rs.34.60 and going on to an intra day high at Rs.36.50. It currently remains over 7.5% higher. Yesterday, Crisil upgraded its sh ...

Sun Pharma Advan down in the red

about 14 years ago

Sun Pharma Advanced Research is deep in the red today. The stock is down currently 3.35% at Rs.124, with an intra day low at Rs.121. Market cap stands at Rs.2934 crore. The stock is in the red following news that the USFDA has rejected its new drug application for an anti-epileptic product. ...

Elder Pharma hits new low

about 14 years ago

Elder Pharma does not seem to be in good health today. The stock opened itself 105 lower, hitting a 52-week low of Rs.224.60 and was frozen on the lower circuit. Almost 2.4 lakh pending sell orders remained on the counter. The stock hit the bottom after institutional investor, Ratnakar Bank ...

Sun Pharma shines bright

about 13 years ago

Sun Pharma has hit a new all-time 52-week today at Rs.597.30, zooming up from its yesterday’s close of Rs.581.30. It has come off the highs but remains in firmly in the green. The stock hit a new high after its rival, Janssen announced that it is facing a shortage of cancer drug, Doxil ...

Sun Pharma in best health!

about 14 years ago

Sun Pharma has hit an all time high at Rs.1066.25 and it remains strongly in the green. Its intra day gain has been the highest since March 16th , 2012. Volumes are huge at over 2 lakh shares being traded. The stock has hit this life time high on the back of its very good numbers for Q4FY13 ...

Elder Pharma hits upper circuit

about 14 years ago

Elder Pharma which closed at Rs.340 yesterday, opened today at Rs.350 and went on to hit the 5% upper circuit filter at Rs.357.15, with almost 17,000 pending buy orders on the counter. The stock hit the roof on news that the company is up on the selling block, scouting around for buyers. It i ...

Elder Pharma on upper circuit

about 14 years ago

Elder Pharma is frozen at 5% upper circuit today at Rs.311 though this was on very low volumes – of just 3788 compared to over 15,000 shares traded over the past two weeks average. The stock had behaved the same way on 11th June and today also the reason is the same – sello ...

GSK Pharma in good health

about 13 years ago

Glaxco Smithkline Pharma is currently the top gainer on the BSE, up over 5% at Rs.2594, with an intra day high at Rs.2684. Volumes are up over 3 times at almost 14,000 shares today. This stock, along with other pharma stocks is up today as investors are seen to be taking long term positions ...

Sun Pharma hits a new high

about 13 years ago

Sun Pharma hit a new 52-week high today at Rs.1111 though it has since then pulled off from these levels and is currently at Rs.1104, just about holding onto the green. The stock hit a high after it announced that it has received final approval from the United States Food and Drug Administra ...

Elder Pharma rises, again

about 13 years ago

Elder Pharma is back in the news and the news remains the same despite persistent denials issued by the company. The stock is in the limelight on news that it is very close to selling its Indian formulation business at US$400-450 million and grapevine has it that the arm of Sanofi is touted to be ...

Glenmark hits new low

about 7 years ago

Glenmark is the top loser on the BSE since the opening bell. The stock hit a new today at Rs.466.65, going down almost 7%.

Sun Pharma brimming with health

about 12 years ago

Sun Pharma which had hit a new high on 7th Nov at Rs.894.90 has today hit another new high at Rs.932. The stock has hit a new high, enthused with the performance of its subsidiary Taro Pharma. For quarter ended 30th Sept 2014, it posted a 48% (YoY) jump in its net profit at $143 ...

Natco Pharma shows a robust jump

about 12 years ago

In an otherwise very lackluster market, Natco Pharma is doing extremely well. The stock hit a new high today at Rs.1679.40 and currently trades over 6% higher at Rs.1647 levels. Pharma stocks as such have a lot of fancy on the bourses and Natco is one of the few much liked stocks. Thus any p ...

Natco Pharma top loser on BSE

about 12 years ago

Natco Pharma is the top loser on the BSE, down almost 5.5% at Rs.1442 and an intra day low at Rs.1409.85. The stock which is in deep red today, on 19th Jan had hit a new 52-week high at Rs.1586.25. The stock has slumped today after the US Supreme Court yesterday, ruled that Teva Pharma could ...

Natco Pharma in the limelight

about 9 years ago

Natco Pharma is up amongst the top five gainers on the BSE since opening bell. From Friday’s close of Rs.797.65, it went up to Rs.849. Its 52-week high is at Rs.1080.

Sun Pharma in great health!

about 10 years ago

Sun Pharma is on a roll today morning and that was but expected given its fantastic performance for Q2FY17. The pharma major posted a whopping 117% (YoY) jump in consolidated net profit at Rs.2235 crore on a 13% rise in net sales at Rs.7764 crore. EBITDA for the quarter came in 69% higher at ...

Sun Pharma gets bitter

about 10 years ago

Sun Pharma is the top loser since the opening bell, going down over 4.5% to Rs.674 levels. It has recovered a bit but remains some 4% down at Rs.378 currently. There was news in one of the business news channels that its Halol plant has been issued a 14 page 483 observation post inspection b ...

Aurobindo Pharma in the docks

about 10 years ago

Aurobindo Pharma is amongst the top losers on the BSE since the opening bell. The stock went down over 4% to Rs.665 levels and from there it recovered to Rs.675 currently, though this is also 3% down. 20 states have accused the company and five more drug companies colluding to fix prices tha ...

Pharma companies get "Trump"ed!

about 10 years ago

Dr.Reddy’s and Sun Pharma are amongst the top losers. The pharma index, which is known as the BSE Healthcare Index is down 1.3% and almost all the drug making companies, except for Biocon and Gufic are in the red. Blame it on Trump! After automobile and IT, the US President-elect has s ...

Marksans Pharma at a new high

about 10 years ago

Marksans Pharma is the top gainer on the BSE Sensex currently; volumes have jumped on the counter by over 7 times and the stock price, intra day, rose almost 17% at Rs.56.25, getting so close to its 52-week high of Rs.58.30.

Ajanta Pharma slips 6%

about 8 years ago

Ajanta Pharma is down in the red today, slipping 6% to Rs.1025.55 and continues to remain around the same levels.

Vista Pharma on 5% LCb

about 9 years ago

Vista Pharma breached the 5% lower circuit at Rs.32.75, the moment is opened up for trading.

Aurobindo Pharma in good health

about 9 years ago

Aurobindo Pharma is today amongst the top five gainers on the BSE, rising over 8% to Rs.794.50. Its 52-week high is at Rs.895.

Vista Pharma locked on 5% UC

about 9 years ago

Vista Pharma has been locked on the 5% UC almost all days through this entire week. Even today, it hit the 5% UC at Rs.41 the moment it opened for trading.

Astrazeneca Pharma jumps 17%

about 9 years ago

Astrazeneca Pharma rose almost 17% to hit a new high at Rs.1278. It had hit a high yesterday too at Rs.1111. Its lifetime high stands at Rs.4798, hit in May 206.

Sun Pharma rises over 6.5%

about 9 years ago

Sun Pharma is among the top five gainers on the BSE. The stock price rose over 6.5% to Rs.576. Volumes are robust at almost 4 times.

Sun Pharma spurts up 4.5%

about 9 years ago

Sun Pharma has been waiting so long for the US FDA to come and re-inspect its Halol facility....

Sun Pharma looks quesy

about 9 years ago

There is a lot of queasiness around the counter of Sun Pharma as the market is very anxious about the upcoming inspection by the US FDA of its Halol plant.

Astrazeneca Pharma in the red

about 10 years ago

Astrazeneca Pharma is deep in the red today, with the stock going down over 6% at Rs.1072 with an intra day low at Rs.1050. The stock is down in the red, reacting to its announcement which came in yesterday. The company stated that AstraZeneca UK has terminated distribution arrangements with ...

Aurobindo Pharma under pressure

about 9 years ago

Aurobindo Pharma is under some major selling pressure today. The stock price slipped 5.5% to Rs.590 from Friday’s close of Rs.624.10. It has recouped a but remains around Rs.600.

Sun Pharma rises 3.5%

about 9 years ago

The moment the market opened for trading, Sun Pharma rose 3.5% at Rs.521.90; after that it slipped and is now trading at Rs.512 levels, up some 1.5%. Its 52-week high is at Rs.709.80 and low at Rs.433.15.

Orchid Pharma down in the red

about 9 years ago

Orchid Pharma is down almost 4% at Rs.12.55. The stock’s 52-week high and low stands at Rs.39.70 and Rs.10.60.

Alembic Pharma jumps up 8%

about 8 years ago

Alembic Pharma rose 8% to hit an intra day high today at Rs.529.90, clocking some three times surge in volume. Its 52-week high and low is at Rs.412.40 and Rs.588 respectively.

Alembic Pharma in the limelight

about 8 years ago

Alembic Pharma rose over 2.5% to Rs.526.75. Its 52-week high and low stands at Rs.588 and Rs.412.40 respectively

Alembic Pharma at new high

about 8 years ago

Alembic Pharma hit a new 52-week high today at Rs.613, up 5%. Volumes too were robust going up 1.2 times.

Sun Pharma at new high

about 8 years ago

Sun Pharma hit a new high today at Rs.614.70, going up over 2%. It has come off the highs and is now trading at Rs.613 levels.

Sun Pharma turns bitter

about 8 years ago

Sun Pharma is alternating with Reliance Naval as the top loser on the BSE, going down almost 5.5% to Rs.640.95. Its 10% UC is at Rs.609.

Alembic Pharma in the limelight

about 8 years ago

Alembic Pharma is the top gainer on the BSE currently. The stock price rose 5% to Rs.639

Strides Pharma jumps up over 4%

about 8 years ago

Strides Pharma Science went up over 4% to Rs.510 and continues to remain firmly in the green.

Sun Pharma looks miserable

about 8 years ago

Sun Pharma is looking pretty miserable today morning. It fell almost 10.5% to Rs.441.95, very close to its 52-week low of Rs.434.80.

Aurobindo Pharma on roller coaster

about 8 years ago

Aurobindo Pharma is having a roller coaster day today, despite all the news being of yesterday! The stock price first fell almost 2.5% to Rs.734 and once there was clarification from the company

Aurobindo Pharma rises over 2.5%

about 8 years ago

Aurobindo Pharma rose over 2.5% to Rs.739 and the stock remains in the green. Its 52-week high and low is at Rs.830 and Rs.527.05 respectively.

Torrent Pharma dispenses bitter pill

about 10 years ago

Torrent Pharma posted a dismal set of numbers for Q2FY17. Total consolidated revenue for the quarter dropped 16% (YoY) at Rs.1429 crore and this was mainly on account of a whopping 55 drop in sales to USA. Net profit came in 59% down at Rs.207 crore. EBITDA for the quarter was also on the de ...

Aurobindo Pharma in good shape

about 10 years ago

Aurobindo Pharma is the top gainer on the BSE since the opening bell. The stock hit an intra day high at Rs.777.50 and currently remains over 5% up at Rs.773 levels. The market is extremely enthused with the company’s Q1FY17 performance. On a 13% (YoY) rise in net profit, the company p ...

Natco Pharma in good health today

about 12 years ago

Natco Pharma seems to be in good health today. Without sulking about the Budget having no sops for the sector, the company and the sector seems to be trudging along on a pretty good road. The stock is today amongst the top five gainers on the BSE, up over 7.5% at Rs.1540 levels. Its 52-week high ...

Hopes spurt Elder Pharma by 17%

about 11 years ago

Shares of Elder Pharma are strongly up in the green, by a whopping 17%, since opening, with the current price being Rs. 98.35. Despite broader markets seem to be giving up the opening gains, Elder’s share price is ruling firm. Volumes on the counter are extra-ordinarily massive – 5 la ...

Sun Pharma gets "Taro"ed!

about 8 years ago

Sun Pharma rose 3.5% in the opening bell session to Rs.429.75; it has come off this current intra day high point and is now at Rs.423 levels

Ajanta Pharma zooms to new high

about 12 years ago

Ajanta Pharma engaged in development, manufacture and marketing of pharmaceutical formulations worldwide. In India, it has a presence in the specialty therapeutic segments of Cardiology, Dermatology, Ophthalmology and Pain management. The stock is in the limelight since today morning, hittin ...

Pharma stocks get beaten down

about 12 years ago

The top four losers amongst the five on the BSE are all pharma stocks. This was the every same sector which was the toast of the street, even till yesterday but today, the tide has suddenly turned. The top loser is Torrent Pharma, down over 3%, Lupin is down 3%, Sun Pharma Advanced Research is do ...

Sun Pharma mourns Daiichi exit

about 12 years ago

Sun Pharma is the top loser on the BSE currently. The counter is witnessing unusual spike up in volumes – up by a unbelievable 29 times though this is on the lower side – from yesterdays close of Rs.1044.10, the stock opened lower at Rs.971.10, going down to Rs.933.10 It is presently ...

Sun Pharma jumps up

about 12 years ago

Sun Pharma is showing some traction in this overall lackluster market. The stock, opened some Rs.10 higher at Rs.956, going up to Rs.960 levels and with profit booking coming at these levels, it has now slipped back to Rs.956, up over 1%. Volumes remain muted. Its 52-weke high is at Rs.1200.70. ...

Aurobindo Pharma in the limelight

about 12 years ago

Aurobindo Pharma has been in the limelight for the past couple of days. First it was the Q4 and FY15 performance on 28th May and the company sweetened up the “below expectations” numbers with a liberal 1:1 bonus and a 100% third interim dividend. Today, once again the shareholder ...

Anuh Pharma at a new high

about 12 years ago

A small cap pharma company, apart of the Eskay (SK) group, Anuh Pharma has hit a new high today at Rs.770 with an over four times jump in volumes. It continues to remain firmly in the green, up almost 16.5% The stock hit the roof after the company announced yesterday that the Board will be me ...

Astrazeneca Pharma hits 20% UC

about 12 years ago

Shares of AstaraZeneca pharma are locked in 20% upper circuit (UC), being frozen at a price of Rs. 1,145.50 per share on NSE. Close to 6.5 lakh shares have been traded on both the exchanges i.e. 2.6% equity has changed hands in first two hours of trade, as company has equity of Rs 5 crore of face ...

Elder Pharma get "calcium" dose!

about 12 years ago

Elder Pharma has been pretty volatile for the past few days, hitting new lows while breaching upper circuits and showing heavy volumes. The stock is currently up almost 4.5% at Rs.83 with an intra day high at Rs.85.80. Volumes are at 45,000 shares getting traded today compared to 2W average of 43 ...

Side-effect of Ranbaxy - Sun Pharma down 13%

about 11 years ago

World’s 5th largest specialty generics pharma co, Sun Pharma Industries, in a surprise move last evening, issued financial alert to analysts and investors over its upcoming first quarter results and also set a very muted tone for results of FY16 as a whole. In a stern reaction, share is dow ...

Torrent Pharma at new life time high

about 11 years ago

Torrent Pharma hit a new life time high today at Rs.1520 with a spike up in volumes by over six times. And the reason for this euphoria on the counter was its exuberant Q1FY16 numbers. On a consolidated total income of Rs.1947 crore, up 75% (YoY), the company posted an almost equal 75% jump ...

Sun Pharma in good health

about 11 years ago

Sun Pharma is one of the smart gainers on the bourses currently. The stock is up over 4.5% at Rs.888 and this is very close to its intra day high of Rs.884.90 rather than the low of Rs.844. The mood on the counter is upbeat after it posted its Q1FY16 numbers yesterday. Though the consolidate ...

Torrent Pharma at new life time high

about 11 years ago

Torrent Pharma hit a lifetime high today at Rs.1720. It has come off this high but remains firmly in the green, up almost 3% at Rs.1650. The stock is reacting to the Q1FY16 results it announced on 27th July. It showed a good performance. Revenue for the quarter came in 75% (YoY) h ...

Sun Pharma in the limelight

about 11 years ago

The stock is up after the company announced today morning that one of its subsidiaries has entered into an agreement and plan of merger with InSite Vision Inc. (InSite Vision) under which a Sun Pharma subsidiary has offered to acquire InSite Vision. InSite Vision focuses on developing new special ...

Aurobindo Pharma in good shape

about 10 years ago

Aurobindo Pharma is currently amongst the top gainers on the BSE, hitting a monthly high at Rs.793, up 4.5%. The company announced today morning that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Rosuvastatin Calcium Tablets, 5 mg ...

Elder Pharma up in the green

about 11 years ago

Elder Pharma had hit a 52-week high at Rs.197.50 last year same day and today, though it has not hit a new high, it is up over 14.5% at Rs.115 levels with an intra day high of Rs.117.40. The stock is up in the green, reacting to its announcement of yesterday that its Board of Directors is me ...

Sun Pharma down in the red

about 11 years ago

Sun Pharma and its subsidiary, Sun Pharma Advanced Research Company (SPARC) are amongst the top losers on the BSE. Sun Pharma is down almost 3.5% at Rs.862.25 with an intra day low of Rs.857.50 and SPARC is down 2.5% at Rs.376.65 with an intra day low of Rs.368.50. The stocks are down as new ...

Sun Pharma hits a new low

about 11 years ago

Sun Pharma is amongst the top losers of the day currently. It hit a new 52-weel low at Rs.745.95. Though it has recovered, it remains at Rs.768 levels, down 4.5%. The market is disappointed with the company’s Q2FY16 performance. It reported a sharp 46% (YoY) drop in its consolidated ne ...

Pharma stocks in the limelight

about 11 years ago

Pharma stocks seem to be in favor today morning. First it was Aurobindo Pharma hitting a new 52-week high at Rs.885. Suven Life Sciences rose over 5% to Rs.275.20. Then Lupin- it was not exactly as trailblazing like these two but it was up almost 1.5% at Rs.1865. Aurobindo hit a high after i ...

Marksans Pharma hits 20% LC

about 11 years ago

Marksans Pharma has breached the 20% lower circuit at Rs.75.80. Volumes are huge at 41 lakh shares traded today alone compared to two-week average volume of over 5 lakh shares. There was news report today morning that its Goa plant has undergone an inspection from the UK drug regulator &ndas ...

Lincoln Pharma locked in 20% LC

about 11 years ago

Lincoln Pharma was locked on the 20% lower circuit at Rs.179.20. The company announced today morning that its largest selling injection, used to treat bacterial infections, chloramphenicol sodium succinate, has been banned in Tanzania. That’s not all – the company’s registration ...

Dishman Pharma jumps on bonus

about 11 years ago

Dishman Pharma shot up into the limelight today morning, following its announcement before the opening bell today. The stock which had closed yesterday at Rs.305, went up to an intra day high at Rs.350. The Board of Directors of the company at its meeting held yesterday has considered and re ...

Sun Pharma gets eclipsed

about 11 years ago

Sun Pharma seems to be ailing today. From yesterday’s close of Rs.865.15, it opened weaker at Rs.855.50, going down to an intra day low at Rs.844.20. The reason? The company, voluntarily recalled 381,120 cartons of osteoporosis drugs in the US and Puerto Rico. This is put up on the US ...

Sun Pharma goes to Japan!

about 11 years ago

Sun Pharma intra day rose over 2.6% to Rs.815; though it has come off this level, it now at Rs.809, some 2% up. The company announced today morning that it has acquired 14 established prescription brands from Novartis AG and Novartis Pharma AG (together ‘Novartis’) in Japan. ...

Orchid Pharma rekindled

about 11 years ago

It is after a long time that Orchid Pharma is in the news. Once a favourite on the bourses, it soon got lost amongst the new entrants in the pharma sector. The stock is today up almost 6.5% at Rs.41 levels and this is after hitting an intra day high at Rs.43.90. Volumes are up over 9 t ...

Dishman Pharma jumps on fixing RD

about 11 years ago

Dishman Pharma is a smart gainer on the bourses currently. The stock price is up over 3% at Rs.355 an this is after an intra day high at Rs.357.65. The stock is up, happy with its announcement that that the Management Committee of Board of Directors of the Company have approved and fixed May ...

Aurobindo Pharma on the radar

about 11 years ago

Aurobindo Pharma is currently the top gainer on the BSE, with the stock price surging over 5% at Rs.809.50 and it presently remains around the same levels. This sudden spike of interest in the stock price is on account of it getting a lot of “buy” calls from several brokerage hou ...

Pharma companies sulk as prices go down

about 11 years ago

Abbott Healthcare, Lupin, Alembic, Alkem Labs, Novartis and many more such pharma companies are trading in the red. Cipla and Sun are just about holding onto the green. It is always seen, what is good for the peopleis not good for the market. If prices are reduced, the markets sulk while peo ...

Glenmark up over 2%

about 13 years ago

Glenmark Pharma is up almost 2.3% at Rs.506, with an intra day high and low at Rs.508.35 and Rs.492.70 respectively. Volumes are reasonable at 21,000 shares. The stock is up on news that the company has received the final approval from the US health regulator for its generic Ointment- D ...

Sun Pharma hits a new low

about 8 years ago

Today morning, Sun Pharma continued to fall as the corporate governance issues blown up by a whistle blower remains a big concern. The stock price fell over 12% to the day’s low point till now at Rs.375.40, hitting a new 52-week low.

Natco Pharma hits new low

about 7 years ago

Natco Pharma opened today at a new 52-week low at Rs.482, going down over 8%. Though it has recovered from this low, the stock remains in the red

Ajanta Pharma in good health

about 7 years ago

Ajanta Pharma is a huge gainer today, figuring among the top five gainers on the BSE. The stock opened higher by 5% at Rs.1252, going on to hit a new 52-week high

Aurobindo Pharma in red

about 7 years ago

Aurobindo Pharma is among the top losers on the BSE currently, going down almost 4% to Rs.588, which is just Rs.20 away from its 52-week low of Rs.566.

Glaxo Pharma Voluntary Open Offer Announced: What Next?

about 13 years ago

GSK Pharma voluntary open offer at Rs. 3,100 per share will see muted response and is likely to remain under subscribed. Taking cues from GSK Consumer's share price performance post closure of its open offer in January this year, retail investors must stay away from the open offer and hold their shares tight.

Torrent Pharma smart gainer

about 7 years ago

Torrent Pharma is among the top three gainers on the BSE since opening bell on the back of its great performance for Q1FY20.

THE CURIOUS CASE OF ASTRAZENECA PHARMA DELISTING

about 12 years ago

Finally, SEBI smelt the rat in Astrazeneca Pharma delisting offer. The way the company, that too an MNC has been conducting itself in this entire delisting process had raised a stink long time ago. First the story of its delisting this year - let us untangle this mess from the end to the beginning. On 4th March, the stock price of the company spurted to a new 52-week high after the company

Sun Pharma falls almost 8%

about 7 years ago

Sun Pharma was among the top five losers on the BSE, going down almost 8% to Rs.406, with volumes showing a rise of over 1.5 times.

Aurobindo Pharma gets "FDA"ed!

about 4 years ago

After Sun Pharma, it is the turn of Aurobindo Pharma today. The stock opened in the red today at Rs.598.90, going down further to hit a new low at Rs.560.60.

GSK Pharma tanks

about 7 years ago

GlaxoSmithKline Pharma is in the red today, going down to an intra day low at Rs.1385, a fall of over 3.5%. The stock has been falling over the last two days, losing 4.7% in this period.

Pharma stocks in focus

about 6 years ago

The top five gainers and more are all pharma stocks – Suven, Novartis, AstraZeneca, Morepen Labs, Shilpa Med, Panacea Bio, Wockhardt, Vivimed Labs, Marksans, Alembic, Cipla, Sun Pharma

Aurobindo Pharma at new low

about 7 years ago

Yesterday too, Aurobindo Pharma had hit a new 52-week low at Rs.427.65 and today too, wthin minutes to opening, it hit another new low at Rs.392.60.

Pharma stocks in reckoning

about 4 months ago

The rally was broad-based, with Dr. Reddy’s gaining up to 2.6%, Cipla nearly 3%, Laurus Labs over 3%, Zydus Lifesciences around 2.8%, Sun Pharma over 1.5%, while Piramal Pharma surged more than 8% on the supply-opportunity trigger.

Alembic Pharma is beaming

about 7 years ago

Alembic Pharma is up today after two days of consecutive fall. It opened almost 2.5% higher at Rs.565 and went on hit an intraday high at Rs.568, a rise of almost 3%.

Pharma stocks in limelight

about 5 years ago

Today, the pharma index is in the green and the BSE Healthcare is up with 71 stocks in the green out of the 89 covered on this index. Dr.Reddys, Cipla, Torrent, JB Chemicals

Glenmark in great health

about 6 years ago

The market is obviously happy with the performance as the stock opened over 4% higher at Rs.495.10, rising up further to Rs.508.50, rising 7%

Glenmark Life

about 5 years ago

Verdict :Good mark for Life
Subscription Start Date :27 Jul 2021 End Date :29 Jul 2021
Issue Size : 1514 crore, Issue Type : Fresh cum OFS
Price Band : Rs.695 to Rs. 720
--------------------------------------------------
Overall Subscription : 44.17x
QIB : 36.97x,HNI :122.54x,Retail :14.63x
Listing Date : 6 Aug 2021, , Listing Price : 750

Gland Pharma hits new low

about 4 years ago

The stock is currently among the top losers on the BSE; it tanked almost 10.5% today to hit a new 52-week low at Rs.1681 with volumes, led mainly by sellers, surging over 3-times.

Pharma and 'Labs' rule today

about 5 years ago

Cipla is the top gainer, up over 7% currently at Rs.964, followed by Dr.Reddy’s, Aurobindo Pharma, Divis Labs, Lupin, Torrent Pharma. Diagnostic stocks – Lalpath Labs, Metropolis, Vijaya Diagnostics,

Torrent Pharma tastes bitter

about 5 years ago

The stock is the top loser on the BSE, opening 7% at Rs.2940, going down 16.5% to an intraday low at Rs.2642, twice hitting the LC today.

Alembic Pharma in limelight

about 5 years ago

The stock rose 1.5% to an intraday high at Rs.772.90; its 52-week high is at Rs.1090 and low is at Rs.715.

SMS Pharma up over 18%

about 5 years ago

The stock opened over 5% higher at Rs.101.55, rising up over 18% to hit an intraday high at Rs.113.75, not too far from its 20% UC of the day at Rs.115.85.

Sun Pharma in the red

about 5 years ago

The stock is in the red today, following 10 observations from the US FDA. The stock opened slightly weak at Rs.879.20 and went down to hit an intraday low at Rs.846.35

Greensignal Bio Pharma

about 10 years ago

Price Band : Rs. - to Rs. -
--------------------------------------------------

Bliss GVS Pharma gets a 'side effect'

about 13 years ago

Bliss GVS Pharma, Mumbai based female contraceptive maker, is down close to 13% at Rs. 33.30, after the company denied its management being in talks with Pfizer to sell a unit or stake in the company. Company has categorically denied running a sale mandate based on the rumours floating on social ...

Alembic Pharma falls 18%

about 4 years ago

The stock fell 18% to Rs.713.70 after it published a small report stating that its business showed a degrowth.

Aurobindo Pharma in limelight

about 4 years ago

The stock which had closed yesterday at Rs.533.30, opened lower today at Rs.531.45 but from there, went on to hit an intraday high at Rs.543.45

Natco Pharma in limelight

about 4 years ago

The stock is in the limelight today, rising over 3.5% to hit an intraday high at Rs.660; it remains closer to its 52-week low at Rs.600.10 than its high of Rs.942.15.

Aurobindo Pharma tastes bitter

about 8 years ago

The market, nevertheless is spooked. It is currently the top loser on the BSE, going down over 6.5% to Rs.676.70.

Aurobindo Pharma gets "FDA"ed!

about 5 years ago

The stock, figuring among top five losers, opening 4% lower at Rs.689.95 and going down further to an intraday low at Rs.685.85 and currently trading around same levels.

Ajanta Pharma hits new high

about 3 years ago

The stock is very much in the limelight since the morning; the stock which had closed yesterday at Rs.1546, opened higher today at Rs.1625 and rose to a new 52-week high

Alembic Pharma on the rise

about 4 years ago

The stock price has reacted positively to this news, rising 7% to hit an intraday high at Rs.619.20 on the back of a very robust surge in volume. Its 52-week high is at Rs.847.95.

Orchid Pharma creating buzz

about 2 years ago

The stock is in the green today; from its close of Rs.1139.85, the stock opened at Rs.1161.75 and rose to an intraday high at Rs.1188.10. Its 52-week high is at Rs.1358.80.

Aurobindo Pharma looks good

about 9 years ago

The stock price is up, reacting positively to both these; going up almost 3% at Rs.750.60; it has come off this level since then and is now at Rs.743 levels.

Sun Pharma gets clouded by FDA again

about 10 years ago

The US FDA had announced its observations of Sun Pharma’s Halol plant on 8th December but the effects of that continue to be felt even today. The stock remains amongst the top losers on the BSE, down 2% at Rs.665 levels. The FDA has made nine observations relating to violations of good ...

Alembic Pharma falls in the red

about 11 years ago

There is no official report as such which one has seen from the US Govt but there are reports that a legislation has been passed wherein the it has made it mandatory for all active pharmaceutical ingredients (API) to be manufactured locally. This means API exports from India to USA will be banned ...

WHO pushes up Anuh Pharma

about 11 years ago

Lesser known Anuh Pharma, with a market cap of over Rs.800 crore, is in the limelight today. The stock rose some 2.5% higher, to spurt up to an intra day high of Rs.339, up almost 9%. It currently remains around 6% up at Rs.330 levels. The company announced yesterday after market hours that ...

Aurobindo Pharma up in the green

about 11 years ago

It seems to be good tidings for Aurobindo Pharma, all around. First the news which came yesterday – another US FDA approval after the two it had received a week ago. The latest one is for manufacture and marketing of Entecavir Tablets, 0.5mg and 1mg (ANDA 206217). The approved ANDA is bioeq ...

Natco Pharma in focus

about 3 months ago

The stock gained in morning trade and touched an intraday high of Rs. 989.40, before trading around Rs. 974.65, up 0.72%.

Sudeep Pharma lists at premium

about 11 months ago

The stock made a strong debut on the bourses today, with its shares listing at Rs.733.95, a healthy premium over the IPO price of Rs.593, reflecting robust investor appetite

Suven Pharma up over 5.5%

about 2 years ago

The stock opened 4.5% higher at Rs.697.35 and rose further to Rs.705, up over 5.5%. Its 52-week high is at Rs.767, hit on 4th Jan’24.

Sun Pharma down 4%

about 4 years ago

The stock opened lower at Rs.1015, going down further to Rs.978, down 4% and is currently trading around the same price. Its 52-week low is at Rs.745.45.

Suven Pharma enhanced!

about 3 years ago

The market is super-happy with this development and the overall optimistic mood on the Street too seems to have rubbed off on the stock. From its close of Rs.630.90, the stock today opened at Rs.653.95

Sun Pharma hits new hjgh

about 3 years ago

From its close of Rs.1296.40, the stock opened higher at Rs.1297.85 and went on to hit a new 52-week high at Rs.1304.10 and is currently trading at Rs.1300 levels.

Gland Pharma up 6.5%

about 3 years ago

The stock opened 1% higher today at Rs.1708.30 and rose to an intraday high at Rs.1817.15, an increase of almost 6.5%. Its 52-week high stands at Rs.1914. Volumes are up today around 5-times.

Emcure Pharma

about 2 years ago

Naam Bade aur Darshan Chote
Subscription Start Date :3 Jul 2024 End Date :5 Jul 2024
Issue Size : Rs. 1,952 cr, Issue Type : Fresh cum OFS
Price Band : Rs.960 to Rs. 1008
--------------------------------------------------
Overall Subscription : 67.87x
QIB : 195.83x,HNI :48.32x,Retail :7.21x,Other :8.81x
Listing Date : 10 Jul 2024, , Listing Price : 1325

Gland Pharma hits new low

about 3 years ago

The stock is a big loser on the bourses today, falling down 20% to hit a new 52-week low at Rs.1070.80. The stock price crashed on the back of its poor show for Q4FY23.

Alembic Pharma hits new low

about 4 years ago

The stock is not doing too well today; from its close of yesterday at Rs.503.20, the stock sunk almost 5.5% to hit a new 52-week low at Rs.476.30.

Suven Pharma gets volatile

about 4 years ago

The stock price is volatile, opening 3% higher at Rs.511, going up further to Rs.520 but soon slipped from there to 485.65 and continues to trade in the red.

Gland Pharma

about 6 years ago

Verdict :Growth and Margins justify Pricing
Subscription Start Date :9 Nov 2020 End Date :11 Nov 2020
Issue Size : 6480 crore, Issue Type : Fresh cum OFS
Price Band : Rs.1490 to Rs. 1500
--------------------------------------------------
Overall Subscription : 2.06x
QIB : 6.4x,HNI :0.51x,Retail :0.24x
Listing Date : 20 Nov 2020, , Listing Price : 1710

Gland Pharma hits new low

about 4 years ago

The stock is currently the top loser on the BSE, opening 3.5% lower at Rs.2148.80 and going down almost 13% to hit a new 52-week low at Rs.1940.

Sun Pharma at new low

about 10 years ago

Sun Pharma, like Tech Mahindra, plunged to a 3.5 year low today morning at Rs.495.55, a sharp drop of 13% and it continues to remain firmly in the red.

GSK Pharma gets thumbs down

about 6 years ago

The stock is down in the red. From its close of yesterday at Rs.1499.55, it went down 2% to Rs.1470. Its 20% LC of the day is at Rs.1199.65.

Strides Pharma in limelight

about 6 years ago

The stock is very much in the limelight today morning, opening with a gap up and rising over 3% to hit an intraday high

Sudeep Pharma

about 11 months ago

In Good Light
Subscription Start Date :21 Nov 2025 End Date :25 Nov 2025
Issue Size : Rs. 895 cr, Issue Type : Fresh cum OFS
Price Band : Rs.563 to Rs. 593
--------------------------------------------------
Overall Subscription : 93.71x
QIB : 213.08x,HNI :116.72x,Retail :15.65x
Listing Date : 28 Nov 2025, , Listing Price : 730

Gland Pharma has grand debut

about 6 years ago

The stock made a grand debut today morning. As against the IPO price of Rs.1500, it got listed on the BSE at Rs.1701

Aurobindo Pharma gets "FDA"ed

about 7 years ago

The market is not soothed by these words of the company. Once this announcement came, the stock slipped down to 466.75 and is currently the top loser on the BSE.

Glenmark down as DGCI pulls it up

about 6 years ago

It slipped over 5% to go down to an intraday low at Rs.408; it has recouped from there and is now trading in the red but at Rs.417 levels.

Aurobindo Pharma jumps 19%

about 7 years ago

The tock is currently the top gainer on the BSE. It opened 10% higher at Rs.550.20, jumping up further to Rs.594, going up almost 19%

Aurobindo Pharma surges 4%

about 6 years ago

The stock opened 2% higher at Rs.800 and went to hit an intraday high at Rs.814, up 4%. It has come off these levels and is now just about holding on to the green

Strides Pharma in the green

about 7 years ago

The stock price has reacted positively to this news. The stock, which had closed yesterday at Rs.466.65, opened at Rs.469

Aurobindo Pharma relapses

about 7 years ago

This flip-flop attitude of the FDA is impacting the shareholders negatively as one can see from the stock price – it is currently the top loser on the BSE; from its close of Rs.599.55 on Thursday

Strides Pharma tumbles

about 6 years ago

The stock price is today in the red. It had closed yesterday at Rs.421.30 and today it opened lower at Rs.425 and going down to an intraday low at Rs.416.

Ajanta Pharma does well

about 6 years ago

From its close of Rs.1442.20 yesterday, it shot up to an intraday high at Rs.1571. It has come off this high

Strides Pharma up over 18%

about 7 years ago

The stock opened 1% higher at Rs.378 and then soon jumped over 18% to hit an intraday high at Rs.442.45. I

Aurobindo Pharma gets 'suited'

about 7 years ago

The stock opened 4% lower at Rs.427.60 and went down to its intraday low at Rs.425.15 but from there it also shot up briefly

Aurobindo Pharma in green

about 7 years ago

It opened with a gain of over 6.5% at Rs.385, and going on to an intraday high at Rs.406.05, a jump of almost 12.5%.

Sun Pharma gets 'FDA'ed

about 7 years ago

The stock price has reacted not-too-well with this news; It fell today after 4 days on consecutive gains. It hit an intraday low in the opening bell session at Rs.426.50, going down 2.8%.

Pharma stocks in focus

about 6 years ago

Thus the second wave has become a reason to celebrate for companies like AstraZeneca, Ipca Labs, Lal Path Labs, Cipla, Dr.Reddy’s , Suven Life Sciences, Divi’s Labs, Thyrocare, Torrent

Glenmark Life does well

about 2 years ago

The stock, which had closed on Friday at Rs.879.80, opened lower today at Rs.835 but soon jumped up to Rs.955.05, and is now trading over 6% higher at Rs.940

Gland Pharma at new high

about 5 years ago

The stock opened today 4% higher at Rs.2900 and went on to hit a new high at Rs.3061, going up over 9.5%. Its 20% UC for the day is at Rs.3351.40.

Lincoln Pharma up over 3%

about 5 years ago

This news pushed the stock price up by over 3% to hit an intraday high at Rs.394.90. Its 52-week high is at Rs.407.70.

Glenmark in good health

about 14 years ago

Glenmark is amongst the big gainers on the BSE currently, the second highest gainer to be more specific. The stock opened at Rs.468.80 and went on to hit an intra day high at Rs.487 and it is currently at Rs.482.15, up over 3%. Volumes are very good at 66,000 shares today compared to the 2-week a ...